GENE TO PATIENT
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

GENE TO PATIENT Trademark

Serial Number: 76131079

GENE TO PATIENT is a trademark filed by MILLENNIUM PHARMACEUTICALS, INC. on September 19, 2000. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MILLENNIUM PHARMACEUTICALS, INC. (425 trademarks)

40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139

Entity Type: 03

Trademark Details

Filing Date

September 19, 2000

Registration Date

Not Registered

Published for Opposition

August 21, 2001

Goods & Services

research and consulting services and data analysis in the fields of genomics, diagnostics, pharmaceuticals, clinical trial design and biotechnology; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks; computer services, namely, creating and customizing databases for others in the field of life sciences; computer services, namely, custom software development; computer services, namely, software support and maintenance; computer services, namely contract computational services; consulting services, namely, research, development, validation and testing services for others in the fields of genomics, life sciences and pharmaceuticals medical and diagnostic services, namely, diagnosing preventing, and predicting diseases, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatments based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services namely, identification and characterization of peptides and proteins for use in developing diagnostic and therapeutic products and services; research services, namely, identifying genes; drug screening using cultured microorganisms; chemical and genetic engineering of therapeutic molecules; pharmaceutical research and development services rendered to others; research services for discovering antibodies, antigens drugs, peptides, proteins, and gene therapy drugs; providing an online electronic database on global computer networks in the field of genomics, diagnostics, pharmacogenomics and biotechnology

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Jan 12, 2004 ABN6
SOU EXTENSION 3 GRANTED
Jun 7, 2003 EX3G
SOU EXTENSION 3 FILED
May 8, 2003 EXT3
SOU TEAS EXTENSION RECEIVED
May 7, 2003 EEXT
SOU EXTENSION 2 GRANTED
Nov 25, 2002 EX2G
SOU EXTENSION 2 FILED
Nov 6, 2002 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 6, 2002 EEXT
SOU EXTENSION 1 GRANTED
May 29, 2002 EX1G
SOU EXTENSION 1 FILED
May 13, 2002 EXT1
PAPER RECEIVED
May 13, 2002 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 13, 2001 NOAM
PUBLISHED FOR OPPOSITION
Aug 21, 2001 PUBO
NOTICE OF PUBLICATION
Aug 1, 2001 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2001 CNSA
ASSIGNED TO EXAMINER
Mar 7, 2001 DOCK
ASSIGNED TO EXAMINER
Feb 27, 2001 DOCK